Physician profile
Melissa M Stamates
NPI 1356637722
$6,521.02
in general payments reported to CMS, 2019-2025
16 companies · $543 in 2025
The $543 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,591 · 2020: $255 · 2021: $296 · 2022: $870 · 2023: $2,017 · 2024: $948 · 2025: $543.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,245 · Travel and Lodging: $1,243 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,244.89 |
| Travel and Lodging | $1,243.18 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,882.54 | 2019-2024 | Adherus Autospray Dural Sealant |
| Globus Medical, INC. | $1,603.37 | 2019-2025 | Corbel, Senza, Creo Mis Stabilization System |
| Boston Scientific Corporation | $1,313.12 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Medtronic, INC. | $850.58 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Mazor X System |
| Abbott Laboratories | $203.95 | 2023-2025 | Proclaim, Eterna |
| Lemaitre Vascular, INC. | $120.31 | 2024 | Anastoclip Gc 8cm (Medium) |
| Arbor Pharmaceuticals, INC. | $100.00 | 2022 | |
| Depuy Synthes Sales INC. | $94.68 | 2024 | |
| Medtronic USA, INC. | $75.98 | 2019 | |
| Nevro Corp. | $65.54 | 2023 | Senza |
| Vertos Medical, INC. | $62.83 | 2023 | Mild Device Kit |
| Astrazeneca Pharmaceuticals LP | $52.55 | 2024 | Andexxa |
| Lilly USA, LLC | $45.29 | 2022-2023 | Reyvow, Emgality |
| Csl Behring | $20.00 | 2023 | Kcentra |
| Novocure INC. | $15.94 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $14.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Stamates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.